Hoppa till innehållet

OMXSPI+0,09%

S&P 500-0,29%

FTSE 100-0,15%

DAX+0,60%

NIKKEI+1,13%
Redeye: Sdiptech - Silencing its critics

Redeye retains its positive view of Sdiptech following a Q1 report that was stronger than our expectations. The company continues to perform strongly with organic growth figures well above peers and sustained margins. We expect continued solid organic growth, healthy margins and strong cash flows ahead. We continue to view the stock as attractive and maintain our base case fair value per share.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Sdiptech - Silencing its critics

Source:MFN
Tillbaka

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill du bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.

spara
1180kr
Prenumerera